Skip to content
Atlas Research Compounds

MOTS-C vs. NAD+

A structured research comparison between MOTS-C and NAD+ across compound identity, research category, evidence maturity, and interpretation boundaries.

Mitochondrial-derived peptide

MOTS-C

Investigated as a mitochondrial-derived signaling peptide in cellular stress and metabolic regulation.

Evidence score2/5

Early human evidence

The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.

Open full profile →

Redox cofactor

NAD+

Functions as an established redox cofactor and enzyme substrate across cellular metabolism.

Evidence score5/5

Established evidence base

The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.

Open full profile →

Side-by-side research context

DimensionMOTS-CNAD+
Catalog identityMOTS-C is mapped to mitochondrial-derived peptide signaling.NAD+ is mapped to established redox biochemistry.
Research categoryMOTS-C is primarily organized around metabolic and mitochondrial stress signaling.NAD+ is primarily organized around cellular metabolism and redox biology.
Interpretive boundaryUse the MOTS-C profile and verified study pages before inferring mechanism or outcomes.Use the NAD+ profile and verified study pages before inferring mechanism or outcomes.

Combined literature starting points

Comparison pages organize differences; they do not establish superiority, equivalence, or individual suitability.

  1. 01

    MOTS-c literature index

    PubMed, U.S. National Library of Medicine · Database

    Open source
  2. 02

    Atlas internal research database

    Internal Research Database · 2026 · Database

    Open source
  3. 03

    NAD+ metabolism literature index

    PubMed, U.S. National Library of Medicine · Database

    Open source